TY - JOUR AU - Loffroy, Romaric AU - Chevallier, Olivier AU - Moulin, Morgan AU - Favelier, Sylvain AU - Genson, Pierre-Yves AU - Pottecher, Pierre AU - Crehange, Gilles AU - Cochet, Alexandre AU - Cormier, Luc PY - 2015 TI - Current role of multiparametric magnetic resonance imaging for prostate cancer JF - Quantitative Imaging in Medicine and Surgery; Vol 5, No 5 (October 26, 2015): Quantitative Imaging in Medicine and Surgery (Medical Imaging in Cancer Research and Clinical Oncology) Y2 - 2015 KW - N2 - Multiparametric magnetic resonance imaging (mp-MRI) has shown promising results in diagnosis, localization, risk stratification and staging of clinically significant prostate cancer, and targeting or guiding prostate biopsy. mp-MRI consists of T2-weighted imaging (T2WI) combined with several functional sequences including diffusion-weighted imaging (DWI), perfusion or dynamic contrast-enhanced imaging (DCEI) and spectroscopic imaging. Recently, mp-MRI has been used to assess prostate cancer aggressiveness and to identify anteriorly located tumors before and during active surveillance. Moreover, recent studies have reported that mp-MRI is a reliable imaging modality for detecting local recurrence after radical prostatectomy or external beam radiation therapy. Because assessment on mp-MRI can be subjective, use of the newly developed standardized reporting Prostate Imaging and Reporting Archiving Data System (PI-RADS) scoring system and education of specialist radiologists are essential for accurate interpretation. This review focuses on the current place of mp-MRI in prostate cancer and its evolving role in the management of prostate cancer. UR - https://qims.amegroups.org/article/view/8064